US Patent Issued to Genzyme on Jan. 27 for "Compositions and methods for treating late-onset Pompe disease" (American, Chinese Inventors)

ALEXANDRIA, Va., Jan. 28 -- United States Patent no. 12,533,396, issued on Jan. 27, was assigned to Genzyme Corp. (Cambridge, Mass.).

"Compositions and methods for treating late-onset Pompe disease" was invented by Patrick Finn (Franklin, Mass.), Alaa Hamed (Chestnut Hill, Mass.), Kristina An Haack (Shanghai) and Catherine Wilson (Durham, N.C.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present application provides methods of treating late-onset Pompe disease (LOPD) using a pharmaceutical composition comprising an oligosaccharide-acid Alpha-glucosidase (GAA) conjugate, such as avalglucosidase alfa."

The patent was filed on June 11, 2021, under Application No. 18/009,234.

*For further information, in...